SCHEMBL6214799

SCHEMBL6214799

CC(C)(C)OC(=O)N1CSC[C@@H]1c1nc(-c2cccc(C#N)c2)no1.N#Cc1cccc(-c2noc(C3CSCN3)n2)c1

nearest known ligand 0.48

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 10/20 0.43
CPT1A P50416 1/20 0.38
SCD O00767 1/20 0.36
SCD5 Q86SK9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5955780 0.92 GRM5 (0.49) GRM5CPT1ASCDSCD5
SCHEMBL5955771 0.92 GRM5 (0.49) GRM5CPT1ASCDSCD5
SCHEMBL5955763 0.81 CHRNB2 (0.45) GRM5
SCHEMBL5329418 0.80 GRM5 (0.54) GRM5
SCHEMBL5955736 0.79 GRM5 (0.56) GRM5CPT1A
SCHEMBL5955577 0.79 GRM5 (0.56) GRM5CPT1A
SCHEMBL5955860 0.78 GRM5 (0.57) GRM5CPT1A
SCHEMBL5955862 0.78 GRM5 (0.57) GRM5CPT1A
SCHEMBL5956161 0.77 GRM5 (0.52) GRM5CPT1A
SCHEMBL5956222 0.77 GRM5 (0.50) GRM5CPT1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581525-A2 COMPOUNDS HAVING AN ACTIVITY AT METABOTROPIC GLUTAMATE RECEPTORS AstraZeneca AB (SE) 2005-10-05 EP disclosed
WO-2004014902-A2 COMPOUNDS HAVING AN ACTIVITY AT METABOTROPIC GLUTAMATE RECEPTORS ASTRAZENECA AB (SE) 2004-02-19 WO disclosed